Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity

Heather J. Zar; Manuele Piccolis; Jonne Terstappen; Natalie I. Mazur; Lobna Gaayeb; Sébastien Morin; Louis Bont

doi:10.1016/S2214-109X(24)00258-4

Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity

Heather J. Zar^*, Manuele Piccolis, Jonne Terstappen, Natalie I. Mazur, Lobna Gaayeb, Sébastien Morin, Louis Bont

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	e1582-e1583
Journal	The Lancet Global Health
Volume	12
Issue number	10
Early online date	24 Jul 2024
DOIs	https://doi.org/10.1016/S2214-109X(24)00258-4
Publication status	Published - Oct 2024

Access to Document

10.1016/S2214-109X(24)00258-4Licence: CC BY-NC-ND

PIIS2214109X24002584Final published version, 56.7 KBLicence: CC BY-NC-ND

Cite this

@article{9de2bf712b854b16b4444cd8b4ceab7a,

title = "Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity",

author = "Zar, {Heather J.} and Manuele Piccolis and Jonne Terstappen and Mazur, {Natalie I.} and Lobna Gaayeb and S{\'e}bastien Morin and Louis Bont",

year = "2024",

month = oct,

doi = "10.1016/S2214-109X(24)00258-4",

language = "English",

volume = "12",

pages = "e1582--e1583",

journal = "The Lancet Global Health",

issn = "2572-116X",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity

AU - Zar, Heather J.

AU - Piccolis, Manuele

AU - Terstappen, Jonne

AU - Mazur, Natalie I.

AU - Gaayeb, Lobna

AU - Morin, Sébastien

AU - Bont, Louis

PY - 2024/10

Y1 - 2024/10

UR - http://www.scopus.com/inward/record.url?scp=85200848177&partnerID=8YFLogxK

U2 - 10.1016/S2214-109X(24)00258-4

DO - 10.1016/S2214-109X(24)00258-4

M3 - Comment/Letter to the editor

C2 - 39067468

AN - SCOPUS:85200848177

SN - 2572-116X

VL - 12

SP - e1582-e1583

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 10

ER -

Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity

Access to Document

Other files and links

Cite this